Drug Discovery World

APRIL 17, 2024

DDW’s Diana Spencer speaks to Josh Mandel-Brehm , CEO of Massachusetts-based biotech CAMP4, to understand the role regulatory RNAs play in gene expression and how the founders overcame the challenge of launching a business based on brand new science. DS: How easy was it to transfer theoretical research into a viable business?

Gene Expression 59

Gene Expression Gene Genetic Disease RNA 59

ACRP blog

MAY 15, 2023

Looking ahead to Clinical Trials Day on May 20, I am excited by the opportunity to work across the industry to address ways we can put patients at the center of the drug development process. We know we cannot do this alone. It is a win for all.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Pharmacy 52

Worldwide Clinical Trials

NOVEMBER 3, 2022

BioPharma Dive interviewed our Derek Ansel on how to conduct psychedelic clinical research. However, this does not address the challenges that diverse patient populations face, so we encourage sponsors to work proactively to address these disparities instead of leaving the U.S. altogether.”. Working with CROs to drive DEI effort.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Drugs 130

XTalks

JUNE 8, 2023

Boyd discussed how sponsors can build a successful partnership with their CRO’s project manager to help advance cell and gene therapy clinical trials. “We all share a passion and a common goal to bring these novel therapeutics to the market for patients that need them,” says Boyd.

Gene Therapy 98

Gene Therapy Gene Production Development 98

XTalks

SEPTEMBER 27, 2023

She provides an insightful peek into how the Alliance is bridging the gaps in information, removing stigmas and offering unparalleled support to colorectal cancer patients. The evidence suggests that innovation across these approaches can change design, stigma, trust, access and ultimately participation in clinical trials.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Research 111

pharmaphorum

JULY 4, 2022

David Weingard, chief impact officer of T1D Moonshot and founder of Cecelia Health, tells us how T1D Moonshot aims to break silos and advance type 1 diabetes prevention and treatment options by utilising numerous partners’ expertise. So, we thought hard about who to bring on,” Weingard says. In the US alone, 37.3

Life Science 104

Life Science Research Doctors Doctor 104

pharmaphorum

DECEMBER 20, 2022

At Roche, we call this personalised healthcare. I see daily how healthcare ecosystems around the world are working to integrate all elements of care into a seamless experience for people. Wearables and digital health technologies are empowering patients to manage and monitor their health outside of a traditional clinical setting.

Genome 104

Genome Genomics Trials Doctors 104

pharmaphorum

SEPTEMBER 28, 2022

Martin Mendoza, PhD, director of health equity and health science policy for the All of Us Research Program at the National Institutes of Health (NIH), tells pharmaphorum about the programme and how it will accelerate research for the benefit of all patients. Potential participants can go through the full enrolment process at the mobile unit.

Research 97

Research Medicine Clinical Trials Clinical Trials 97

WCG Clinical

JULY 17, 2023

To do this, we must reimagine clinical research, from how we design and staff trials to how we compensate sites and patients. This suggests that we should educate and inform patients well before that steady recruitment pipeline begins. So how do we engage them? You don’t want the placebo.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

AUGUST 26, 2021

The pandemic has transformed many aspects of our industry and one area that change has come to is patient engagement within clinical trials, where it would now seem unusual were we to not consider the patient voice when it comes to recruiting trial participants. Inclusivity and trust.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Marketing 104

XTalks

MAY 16, 2022

Now the Illinois-based medical device and health care company has partnered with the non-profit organization Women as One to start a new program called CLIMB Research. The featured speakers will discuss how to identify strategies to increase interest, accessibility and trial participation for patients in underrepresented populations.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Nurses 98

pharmaphorum

JUNE 30, 2022

At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally.

Trials 62

Trials Development Drugs Clinical Trials 62

pharmaphorum

JULY 26, 2021

We are addressing issues of mistrust and working to reduce systemic issues that deter communities of colour from participating in clinical trials, so that those patients who want to participate, can.”. Ultimately, they talk about the crucial issue of building trust and acknowledging past wrongs. Practices and processes.

Clinical Trials 113

Clinical Trials Clinical Trials Trials Production 113

ACRP blog

APRIL 10, 2023

One of the complex hurdles we face in our industry is ensuring trials include the diverse patients we serve. We cannot advance scientific knowledge without an understanding of how our treatments work in all people. Put simply, to develop medicines for all, we must conduct research for all.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

World of DTC Marketing

JANUARY 26, 2021

4our: How do we enhance our relationship with our online agency? Some are comical because they seek to impress clients rather than talk about how to drive brand objectives. 5ive: How can I “sell” digital to management? In your story, you also need to talk about trust.

Branding 180

Branding Production Marketing Pharma Companies 180

pharmaphorum

JANUARY 25, 2021

Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. It has been thrilling to watch how COVID-19 has catapulted the pace of collaboration among regulatory agencies. Proactive public engagement efforts need to replace age-old recruitment and retention processes”.

Clinical Research 123

Clinical Research Research Clinical Trials Clinical Trials 123

pharmaphorum

SEPTEMBER 15, 2020

Whenever we talk to brands, they’re always thinking about what agility means to them, both internally and externally. The ‘agenda’ for a digitally-native brand is to connect with the customer, changing with their needs, instilling trust and building loyalty. We’re all trying to find ways to automate.

Branding 125

Branding Marketing Pharma Companies Life Science 125

pharmaphorum

FEBRUARY 5, 2021

Amanda Barrell reports from a panel at the Patients as Partners Europe conference on remote clinical trials. Patients as Partners. A panel discussion held at last week’s virtual Patients as Partners Europe conference talked about the difference between “connectivity” and “being connected”. Building engagement. Added value.

Clinical Trials 133

Clinical Trials Clinical Trials Trials Doctors 133

Advarra

AUGUST 14, 2023

The clinical trial process is both expensive and time-consuming, and ends more often in failure than success. How can we fill the gap? How can we improve that statistic? How can the research industry work to build more trust amongst these groups? While 69.7% have reported actually taking part in one.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

JUNE 21, 2021

Exploring next steps, they talked about the value of sharing knowledge and how the “COVID effect” could accelerate progress. We do not work in a bubble: we are part of society. We listen to politicians, the general public, the media. We listen to our families, and what our kids are saying. Knowledge pool.

Manufacturing 62

Manufacturing Vaccination Vaccine Production 62

pharmaphorum

MAY 20, 2022

So if you take that as a foundation, we have a legitimate reason to play in that space because of the familiarity trust that patients have with CVS. When we juxtapose that with what patients think about CVS as a partner in clinical research, it’s dramatically different. So how does it work?

Clinical Trials 89

Clinical Trials Clinical Trials Trials Clinical Research 89

pharmaphorum

OCTOBER 22, 2021

The digital format also helps to avoid cultural or educational bias in testing, and helps to avoid scenarios where people tested on multiple occasions learn how to score better, masking increases in impairment, said Cognetivity.

FDA Approval 130

FDA Approval Clinical Trials Clinical Trials Antibody 130

Drug Discovery World

JULY 8, 2022

Cambridge Biomedical Centre is co-located with the University of Cambridge School of Clinical Medicine and is home to hospitals such as Addenbrookes and Royal Papworth as well as facilities for Cambridgeshire and Peterborough NHS Foundation Trust. . We already have a strong pipeline of customer interest and are expecting more to come.” .

Life Science 52

Life Science Development Medicine Scientist 52

pharmaphorum

JANUARY 18, 2021

Karina Malhotra from Acumentice explores how digital tech and data could help address the NHS elective care backlog in 2021 and beyond. This has posed two challenges – clearing the existing and growing backlog and instigating better systems and processes in doing so to prevent the same problem repeating in the future.

Containment 80

Containment Development 80

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. When examining how companies are engaging with their customers and other stakeholders, pharma has not lagged behind.

Regulation 96

Regulation Marketing Sales Branding 96

Cloudbyz

MARCH 27, 2023

Abstract Real-time signal management is a critical process in drug development that involves the continuous monitoring of data to identify and respond to potential safety and efficacy issues. To support this process, many drug developers have turned to data visualization tools like Tableau.

Drugs 52

Drugs Compliance Development Production 52

pharmaphorum

FEBRUARY 3, 2022

Many think their decision to either fight, flee or freeze is a conscious one – but it’s not: under extreme pressure, our ancient brain (the paleomammalian complex, or limbic system) makes an instant call of how to react. You’ll notice how much calmer this simple technique allows you to keep. A trusted partner.

Life Science 98

Life Science Hormones Sales Marketing 98

pharmaphorum

SEPTEMBER 27, 2021

As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says pharma should reassess how it conducts clinical trials. To address this problem, businesses operating in this sector should go back to the beginning of the process and look at how they conduct clinical trials.

Clinical Trials 118

Clinical Trials Clinical Trials Trials Vaccination 118

pharmaphorum

NOVEMBER 19, 2020

By adopting a design-led, solutions-based approach to communications, companies can help healthcare professionals (HCPs) to better meet the needs of their patients through their comms, taking a scientific approach to creating clear, rational processes built on discovery, definition, development, and delivery in every aspect of healthcare.

Compliance 80

Compliance Marketing Sales Development 80

pharmaphorum

DECEMBER 1, 2022

A recent survey of clinical trial professionals found that more than two-thirds of respondents (61%) believe giving patients choice will have a positive impact on clinical research, and well over half (58%) said that their organisations plan to give patients the option to choose how they participate in clinical trials moving forward.

Clinical Trials 109

Clinical Trials Clinical Trials Trials Clinical Research 109

pharmaphorum

AUGUST 19, 2021

“This can result in failure to identify and use effective interventions or the continuing use of ineffective or hazardous interventions,” they said, adding that these issues waste resources, cause unnecessary harm or suffering, and reduce trust in the system. Underpinning principles. But the space is evolving.

Trials 104

Trials Clinical Trials Clinical Trials Life Science 104

FDA Law Blog

JUNE 23, 2021

In 2012 we at the Agency, under Dr. Janet Woodcock’s leadership, identified the need for more systematic patient engagement — a way to improve representativeness and be more proactive rather than reactive to interacting with patient communities. The practice of medicine was viewed as paternalistic.

FDA Approval 52

FDA Approval Drugs Development Clinical Trials 52

pharmaphorum

MAY 21, 2021

. “CE marking our software as a medical device whilst maintaining the ability to move fast and innovate was a challenging process,” said Kirby, who is chief technology officer at Vinehealth. ” Feedback from patients showcases how with the support of the app they have felt more in control of their cancer care. .”

Nurses 57

Nurses Doctors Doctor Development 57

The Pharma Data

SEPTEMBER 14, 2020

NHS Providers, which represents hospital trusts in England, said staff are having to self-isolate rather than work because they cannot get tests for themselves or family members. ‘Working in the dark’ Latest figures from last week showed around 220,000 tests are processed each day. “I have to say I burst into tears.

Nurses 52

Nurses Doctors Doctor Antibody 52

Drug Discovery World

JANUARY 24, 2023

“We’re calling this a virtual clinical trial, because we used real, deidentified patient data to simulate health outcomes,” says Wenrui Hao, Associate Professor of Mathematics at Penn State, lead author and co-principal investigator. How will a treatment fit into the existing competitive landscape? So where to start?

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

XTalks

NOVEMBER 15, 2023

How does the biotech industry respond to these challenges? Biotechs are now increasingly taking up a transversal perspective, focusing on their entire development process as well as the market dynamics awaiting their products. How should biotech leaders approach planning?

Marketing 64

Marketing Production Trials Clinical Trials 64

pharmaphorum

NOVEMBER 13, 2020

To discover new medicines, high quality research must be translated into new drug candidates or technologies through an industrial process of refinement and structured experimentation. Activities of focus for the partners can be broadly categorised as follows: Identifying research that can be supported at its earliest stages.

Medicine 52

Medicine Research Development Packaging 52